Institute of Personalized Medicine - PUMA IPM
Pharmacogenomics aims at understanding how variations in the human genome affect the response to medications.
Our researchers are working to generate new knowledge, and to develop tools and algorithms that can help in personalizing medicine utilizing a patient’s genetic profile and other factors to achieve maximum therapeutic benefit with minimum toxicity.
Pamala Jacobson received the Sara Evans Faculty Woman Scholar/ Leader Award from the University of Minnesota Women’s Center, Office for Equity and Diversity and was honored at their Celebrating Changemakers Awards event on October 11, 2018.
This session highlighted the social and cultural challenges associated with providing care to local Native American tribes in Minnesota, who face larger health disparities than other populations. Pamala Jacobson, Professor, Experimental and Clinical Pharmacology, University of Minnesota, Anne Joseph, Wexler Professor of Medicine, Division of General Internal Medicine, University of Minnesota and Kris Rhodes, CEO, American Indian Cancer Foundation joined The Atlantic’s Steve Clemons to talk about why Minnesota is aptly positioned to do this important work in Native American tribes.
Samuel is a PhD Candidate in the Experimental and Clinical Pharmacology department. During his time in the program Samuel has pursued various avenues of research related to precision medicine in neuropharmacology with a focus on anti-seizure drugs.
Weekly Genomics Scan
This weekly update features emerging roles of human genomics, testing and interventions in a wide variety of noncommunicable diseases across the life span.
Genomic Testing to Individualize Drug Therapy
The 2018 Pharmacogenomics Confernece on June 22 was at capacity with over 310 registrants in attendance. Topics included: cancer somatic mutations and selection of targeted therapies, emerging PGx areas. Read about the event here.